---
title: "ReShape Lifesciences (RSLS.US) — 財務報表"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/RSLS.US/norm.md"
symbol: "RSLS.US"
name: "ReShape Lifesciences"
parent: "https://longbridge.com/zh-HK/quote/RSLS.US.md"
datetime: "2026-03-04T04:08:45.281Z"
locales:
  - [en](https://longbridge.com/en/quote/RSLS.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/RSLS.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/RSLS.US/norm.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/RSLS.US/norm.md) | [简体中文](https://longbridge.com/zh-CN/quote/RSLS.US/norm.md)


# ReShape Lifesciences (RSLS.US) — 財務報表

## 損益表 (USD)

| 指標 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| 每股收益 | 18.98 | -61.71 | -77.68 | -91.69 | -135.37 |
| ROE | 1206.96% | -1141.65% | -279.70% | -168.58% | -156.68% |
| 營業收入 | 1.11M | 1.80M | 2.29M | 1.97M | 1.94M |
| 凈利潤 | 1.47M | -1.76M | -1.58M | -1.59M | -2.19M |

## 資產負債表 (USD)

| 指標 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| 資產與負債 | 6.48M | 4.79M | 5.62M | 6.39M | 8.23M |
| 權益乘數 | 5.27 | -18.94 | 3.78 | 2.11 | 1.82 |
| 每股凈資產 | 9.24 | -8.66 | 52.75 | 149.75 | 280.27 |
| 資產周轉率 | 0.9753 | 1.04 | 1.22 | 0.8820 | 0.6781 |

## 現金流量表 (USD)

| 指標 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
| --- | --- | --- | --- | --- | --- |
| 經營現金流 | -2.12M | -687000.00 | -311000.00 | -1.36M | -2.07M |
| 投資現金流 | - | - | - | - | - |
| 融資現金流 | 3.95M | 653000.00 | 0.0000 | 24000.00 | - |
| 自由現金流 | -1.07M | 466750.00 | 198375.00 | -1.05M | -1.24M |